The lectin-like domain of complement receptor 3 protects endothelial barrier function from activated neutrophils

Journal of Immunology

Volumn 173, Issue 2, 2004, Pages 1284-1291

  Tsikitis, Vassiliki L ^a   Morin, Nicole A ^a   Harrington, Elizabeth O ^a   Albina, Jorge E ^a   Reichner, Jonathan S ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; BETA2 INTEGRIN; CD11 ANTIGEN; CD18 ANTIGEN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; INTERCELLULAR ADHESION MOLECULE 1; LECTIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE PERMEABILITY; CHEMOTAXIS; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; ENDOTHELIUM CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 3142690479     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.2.1284     Document Type: Article

References (51)

1. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11.
2. 2 integrins and selectin ligands. Curr. Opin. Hematol. 9:30.
3. Vedder, N. B., R. K. Winn, C. L. Rice, E. Y. Chi, K. E. Arfors, and J. M. Harlan. 1988. A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J. Clin. Invest. 81:939.
4. Mileski, W. J., R. K. Winn, N. B. Vedder, T. H. Pohlman, J. M. Harlan, and C. L. Rice. 1990. Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery 108:206.
5. Simpson, P. J., R. F. Todd, 3rd, J. K. Mickelson, J. C. Fantone, K. P. Gallagher, K. A. Lee, Y. Tamura, M. Cronin, and B. R. Lucchesi. 1990. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation 81:226.
6. Gallin John, S. R. 1999. Inflammation Basic Principles and Clinical Correlates. Lippincott Williams and Wilkins, Philadelphia.
7. Lu, H., C. W. Smith, J. Perrard, D. Bullard, L. Tang, S. B. Shappell, M. L. Entman, A. L. Beaudet, and C. M. Ballantyne. 1997. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J. Clin. Invest. 99:1340.
8. 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 5:653.
9. Diamond, M. S., J. Garcia-Aguilar, J. K. Bickford, A. L. Corbi, and T. A. Springer. 1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120:1031.
10. Diamond, M. S., and T. A. Springer. 1993. A subpopulation of Mac-1 (CD11b/ CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell Biol. 120:545.
11. Miller, J. L., and A. Castella. 1982. Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood 60:790.
12. Walzog, B., D. Schuppan, C. Heimpel, A. Hafezi-Moghadam, P. Gaehtgens, and K. Ley. 1995. The leukocyte integrin Mac-1 (CD11b/CD18) contributes to binding of human granulocytes to collagen. Exp. Cell Res. 218:28.
13. Nathan, C., S. Srimal, C. Farber, E. Sanchez, L. Kabbash, A. Asch, J. Gailit, and S. D. Wright. 1989. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J. Cell Biol. 109:1341.
14. 2 as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood 99:4457.
15. 2 ligand binding promiscuity. J. Biol. Chem. 277:48635.
16. Russell, D. G., and S. D. Wright. 1988. Complement receptor type 3 (CR3) binds to an Arg-Gly-Asp-containing region of the major surface glycoprotein, gp63, of Leishmania promastigotes. J. Exp. Med. 168:279.
17. 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell 61:1375.
18. Forsyth, C. B., and H. L. Mathews. 1996. Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans. Cell. Immunol. 170:91.
19. Ross, G. D., J. A. Cain, B. L. Myones, S. L. Newman, and P. J. Lachmann. 1987. Specificity of membrane complement receptor type three (CR3) for β-glucans. Complement 4:61.
20. Ross, G. D., V. Vetvicka, J. Yan, Y. Xia, and J. Vetvickova. 1999. Therapeutic intervention with complement and β-glucan in cancer. Immunopharmacology 42:61.
21. Sitrin, R. G., R. F. Todd, 3rd, H. R. Petty, T. G. Brock, E. Albrecht, and M. R. Gyetko. 1996. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J. Clin. Invest. 97:1942.
22. 2 integrins. J. Immunol. 162:6792.
23. Vetvicka, V., B. P. Thornton, T. J. Wieman, and G. D. Ross. 1997. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and β-glucan-primed CR3 (CD11b/CD18). J. Immunol. 159:599.
24. Wegener, J., C. R. Keese, and I. Giaever. 2000. Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces. Exp. Cell Res. 259:158.
25. Keese, C. R., K. Bhawe, J. Wegener, and I. Giaever. 2002. Real-time impedance assay to follow the invasive activities of metastatic cells in culture. BioTechniques 33:842.
26. 1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J. Cell Biol. 145:413.
27. 2 integrins triggers neutrophil-dependent alteration in endothelial barrier function. J. Exp. Med. 191:1829.
28. Gautam, N., P. Hedqvist, and L. Lindbom. 1998. Kinetics of leukocyte-induced changes in endothelial barrier function. Br. J. Pharmacol. 125:1109.
29. Wary K., D. M., A. Mariotti, and F. Giancotti. 1999. Integrin Protocols. Humana Press, Totowa.
30. Ross, G. D., R. A. Thompson, M. J. Walport, T. A. Springer, J. V. Watson, R. H. Ward, J. Lida, S. L. Newman, R. A. Harrison, and P. J. Lachmann. 1985. Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1. Blood. 66:882.
31. Lowe, E. P., D. Wei, P. J. Rice, C. Li, J. Kalbfleisch, I. W. Browder, and D. L. Williams. 2002. Human vascular endothelial cells express pattern recognition receptors for fungal glucans which stimulates nuclear factor κB activation and interleukin 8 production. Winner of the Best Paper Award from the Gold Medal Forum. Am. Surg. 68:508.
32. Sans, E., E. Delachanal, and A. Duperray. 2001. Analysis of the roles of ICAM-1 in neutrophil transmigration using a reconstituted mammalian cell expression model: implication of ICAM-1 cytoplasmic domain and Rho-dependent signaling pathway. J. Immunol. 166:544.
33. Zen, K., Y. Liu, D. Cairo, and C. A. Parkos. 2002. CD11b/CD18-dependent interactions of neutrophils with intestinal epithelium are mediated by fucosylated proteoglycans. J. Immunol. 169:5270.
34. Furie, M. B., M. C. Tancinco, and C. W. Smith. 1991. Monoclonal antibodies to leukocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 78:2089.
35. Issekutz, A. C., D. Rowter, and T. A. Springer. 1999. Role of ICAM-1 and ICAM-2 and alternate CD11/CD18 ligands in neutrophil transendothelial migration. J. Leukocyte Biol. 65:117.
36. Smith, C. W., S. D. Marlin, R. Rothlein, C. Toman, and D. C. Anderson. 1989. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J. Clin. Invest. 83:2008.
37. Shaw, S. K., P. S. Bamba, B. N. Perkins, and F. W. Luscinskas. 2001. Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J. Immunol. 167:2323.
38. 2-integrin glycoprotein. Crit. Rev. Immunol. 20:197.
39. Vetvicka, V., B. P. Thornton, and G. D. Ross. 1996. Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest. 98:50.
40. Xia, Y., G. Borland, J. Huang, I. F. Mizukami, H. R. Petty, R. F. Todd, 3rd, and G. D. Ross. 2002. Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. J. Immunol. 169:6417.
41. Brown, G. D., and S. Gordon. 2001. Immune recognition: a new receptor for β-glucans. Nature 413:36.
42. Czop, J. K., and J. Kay. 1991. Isolation and characterization β-glucans receptors on human mononuclear phagocytes. J. Exp. Med. 173:1511.
43. Zimmerman, J. W., J. Lindermuth, P. A. Fish, G. P. Palace, T. T. Stevenson, and D. E. DeMong. 1998. A novel carbohydrate-glycosphingolipid interaction between a β-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem. 273:22014.
44. Brown, G. D., P. R. Taylor, D. M. Reid, J. A. Willment, D. L. Williams, L. Martinez-Pomares, S. Y. Wong, and S. Gordon. 2002. Dectin-1 is a major β-glucan receptor on macrophages. J. Exp. Med. 196:407.
45. Willment, J. A., S. Gordon, and G. D. Brown. 2001. Characterization of the human β-glucan receptor and its alternatively spliced isoforms. J. Biol. Chem. 276:43818.
46. Taylor, P. R., G. D. Brown, D. M. Reid, J. A. Willment, L. Martinez-Pomares, S. Gordon, and S. Y. Wong. 2002. The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169:3876.
47. Gautam, N., A. M. Olofsson, H. Herwald, L. F. Iversen, E. Lundgren-Akerlund, P. Hedqvist, K. E. Arfors, H. Flodgaard, and L. Lindbom. 2001. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat. Med. 7:1123.
48. Dallegri, F., and L. Ottonello. 1997. Tissue injury in neutrophilic inflammation. Inflamm. Res. 46:382.
49. Narravula, S., P. F. Lennon, B. U. Mueller, and S. P. Colgan. 2000. Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function. J. Immunol. 165:5262.
50. Lennon, P. F., C. T. Taylor, G. L. Stahl, and S. P. Colgan. 1998. Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J. Exp. Med. 188:1433.
51. Babineau, T. J., A. Hackford, A. Kenler, B. Bistrian, R. A. Forse, P. G. Fairchild, S. Heard, M. Keroack, P. Caushaj, and P. Benotti. 1994. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch. Surg. 129:1204.